3:15 pm Developing a Novel Cancer Therapeutic that Combines Checkpoint Blocking Function with Fc-Mediated Tumor Cell Killing
Time: 3:15 pm
day: Conference Day One
Details:
- Discussing antibody generation and screening
- Assessing the blocking and killing function
- Learning lessons from translational studies to support clinical development
